Current evidence suggest that intranasal delivery of drugs or particles allows their direct brain targeting [13,14,15,16,17] and we hypothesized that delivery of CNP directly into the brain would prevent the behavioral changes in experimental AD model. This evidence concerns the gene CNP and Alzheimer disease.